Craft

Xintian Pharmaceutical

Stock Price

¥11.5

2024-10-29

Market Capitalization

¥2.7 B

2024-10-29

Revenue

¥734.6 M

FY, 2025

Xintian Pharmaceutical Summary

Company Summary

Overview
Xintian Pharmaceutical (贵阳新天药业股份有限公司) is engaged in the production and sale of medicines. It provides capsules, oral liquids, gels, granules, tablets, syrups, etc. The company’s products are used in the treatment of antitumor, gynecological, urinary, breast thyroid, blood, heat-clearing, oral class, and cardiovascular diseases.
Type
Public
Status
Active
Founded
1995
Website
http://www.gyxtyy.com
Cybersecurity rating
Sectors

Table of Contents

Xintian Pharmaceutical Financials

Summary Financials

Revenue (Q1, 2026)
¥173.6M
Gross profit (Q1, 2026)
¥124.5M
Net income (Q1, 2026)
¥3.5M
Cash (Q1, 2026)
¥167.1M
EBIT (Q1, 2026)
¥9.7M
Enterprise value
$3.1B

Footer menu